Effect of high DHA and ARA fortification on lipid oxidation of infant formula powder

Effect of high DHA and ARA fortification on lipid oxidation of infant formula powder

ABSTRACTOur objective was to assess the impact of fortified high-dose docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula powders (IFs) on stability. We compared and evaluated the stability of IFs containing high and low doses of DHA and ARA over a 6-month storage period at 37°C....

Full description

Bibliographic Details
Main Authors:	Hong-Xin Jia, Ye-Zhi Qu, Wen-Liang Chen, Mi-Ya Su
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	CyTA - Journal of Food
Subjects:	Infant formula unsaturated fatty acid volatile organic compounds docosahexaenoic acid antioxidant
Online Access:	https://www.tandfonline.com/doi/10.1080/19476337.2023.2300812

Similar Items

Effect of high DHA and ARA fortification on non-enzymatic browning of infant formula powder
by: Hong-Xin Jia, et al.
Published: (2024-12-01)

Iron and DHA in Infant Formula Purchased in the US Fails to Meet European Nutrition Requirements
by: Alexander Strzalkowski, et al.
Published: (2023-04-01)

The Impact of Linoleic Acid on Infant Health in the Absence or Presence of DHA in Infant Formulas
by: Alexandra W. C. Einerhand, et al.
Published: (2023-05-01)

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
by: Félix Castillo Salinas, et al.
Published: (2022-11-01)

AA and DHA are decreased in paediatric AD/HD and inattention is ameliorated by increased plasma DHA
by: John J. Miklavcic, et al.
Published: (2023-03-01)

Lipid and polyunsaturated fatty acid contents in infant formulas in reference to the Codex Alimentarius
by: Mahyara Markievicz Mancio Kus-Yamashita, et al.
Published: (2016-02-01)

Lipid and polyunsaturated fatty acid contents in infant formulas in reference to the Codex Alimentarius
by: Mahyara Markievicz Mancio Kus-Yamashita, et al.
Published: (2016-02-01)

Lipid and polyunsaturated fatty acid contents in infant formulas in reference to the Codex Alimentarius
by: Mahyara Markievicz Mancio Kus-Yamashita, et al.
Published: (2016-02-01)

Evaluation of Fatty Acid and the Composition of Six Different Species of Freshwater Fish in the North of Algeria
by: E. Sabba, et al.
Published: (2023-09-01)

Maternal and Neonatal Polyunsaturated Fatty Acid Intake and Risk of Neurodevelopmental Impairment in Premature Infants
by: Rory J. Heath, et al.
Published: (2022-01-01)

Docosahexaenoic acid (DHA), essentiality and requirements: why and how to provide supplementation
by: Alfonso Valenzuela, et al.
Published: (2006-06-01)

Lipids for infant formulas
by: Delplanque Bernadette, et al.
Published: (2018-05-01)

DHA and ARA and development of brain and eyes ‐ Scientific substantiation of a health claim related to Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) and support of the neural development of the brain and eyes pursuant to Article 14 of Regulation (EC) No 1924/2006
by: European Food Safety Authority (EFSA)
Published: (2008-09-01)

Effect of long-chain polyunsaturated fatty acids on infant development
by: O. N. Komarova
Published: (2020-07-01)

Producing Omega-3 Polyunsaturated Fatty Acids: A Review of Sustainable Sources and Future Trends for the EPA and DHA Market
by: Laura Oliver, et al.
Published: (2020-12-01)

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
by: Félix Castillo, et al.
Published: (2021-04-01)

Docosahexaenoic Acid in Formulas for Term Infants: The Way from Pioneer Idea to Mandatory Dietary Recommendation
by: Tamás Decsi, et al.
Published: (2023-06-01)

Impact of Maternal Fish Consumption on Serum Docosahexaenoic Acid (DHA) Levels in Breastfed Infants: A Cross-Sectional Study of a Randomized Clinical Trial in Japan
by: Ayu Kasamatsu, et al.
Published: (2023-10-01)

The role of docosahexaenoic acid in neuronal development and the importance of DHA supplementation during pregnancy
by: Aleksandra Karmańska, et al.
Published: (2023-10-01)

fabH deletion increases DHA production in Escherichia coli expressing Pfa genes
by: Laura Giner-Robles, et al.
Published: (2018-06-01)

A Comparative Analysis of Lipid Digestion in Human Milk and Infant Formulas Based on Simulated In Vitro Infant Gastrointestinal Digestion
by: Lu Liu, et al.
Published: (2022-01-01)

Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort
by: Antonio Gázquez, et al.
Published: (2021-03-01)

Polyunsaturated Fatty Acid Intake during Complementary Feeding and Neurodevelopmental Outcome in Very Low Birth Weight Infants
by: Melanie Gsoellpointner, et al.
Published: (2023-07-01)

Ostrich oil as a fat substitute in milk‐based infant formula
by: Mohsen Dalvi‐Isfahan, et al.
Published: (2023-04-01)

Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase[S]
by: Eleanor P. Dobson, et al.
Published: (2013-05-01)

Fatty acid composition of human milk and infant formulas
by: Ivančica Delaš, et al.
Published: (2005-04-01)

Stool microbiome, pH and short/branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age
by: Car Reen Kok, et al.
Published: (2020-11-01)

Athletes Can Benefit from Increased Intake of EPA and DHA—Evaluating the Evidence
by: Maja Tomczyk, et al.
Published: (2023-11-01)

Update on the infant supplementation with vitamin D3, vitamin K1 and DHA
by: Tena Niseteo
Published: (2024-06-01)

Safety of oil from Schizochytrium limacinum (strain TKD‐1) for use in infant and follow‐on formula as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-12-01)

Competition between 24:5n-3 and ALA for Δ6 desaturase may limit the accumulation of DHA in HepG2 cell membranes
by: Roxanne Portolesi, et al.
Published: (2007-07-01)

Safety of oil from Schizochytrium sp. (strain CABIO‐A‐2) for use in infant and follow‐on formula as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-12-01)

A More Comprehensive Approach to the Neuroprotective Potential of Long-Chain Polyunsaturated Fatty Acids in Preterm Infants Is Needed—Should We Consider Maternal Diet and the n-6:n-3 Fatty Acid Ratio?
by: Susanna Klevebro, et al.
Published: (2020-01-01)

Research Progress of Mitochondrial-Mediated Docosahexaenoic Acid (DHA) Antioxidation
by: Xiaoting SUN, et al.
Published: (2022-05-01)

Neurons and the DHA principle /
by: Valentine, R. C. (Raymond Carlyle), 1936-, et al.
Published: (2013)

Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies
by: Dhavamani Sugasini, et al.
Published: (2020-10-01)

Safety of oil from Schizochytrium limacinum (strain FCC‐3204) for use in infant and follow‐on formula as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2021-01-01)

Value of long-chain polyunsaturated fatty acids for infants’ health and development
by: Д. О. Добрянський, et al.
Published: (2019-06-01)

The stability of milk-based infant formulas during accelerated storage
by: Hong-xin Jia, et al.
Published: (2019-01-01)

Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
by: Karen P. Best, et al.
Published: (2023-01-01)